Leidos Holdings, Inc. — 2024 Q1
Transcript
Each turn shows the speaker, their inferred role, the section, and that turn's net sentiment (×1000).
Greetings, and welcome to Leidos First Quarter 2024 Earnings Conference Call. At this time, all participants are in a lister-only mode. A brief question-and-answer session will follow the formal presentation. Please note this conference is being recorded.
Thank you, operator, and good morning, everyone. I'd like to welcome you to our First Quarter Fiscal Year 2024 Earnings Conference Call. Joining me today are Tom Bell, our CEO; and Chris Cage, our Chief Financial Officer. Today's call is being webcast on the Investor Relations portion of our website, where you'll also find the earnings release and supplemental financial presentation slides that we'll use during today's call.
Thank you, Stuart, and good morning, everyone. It's very good to be with you again today. And I'm thrilled to report a very robust start for Leidos in 2024, a substantial raise to our full year guidance and some additional details around the purposeful steps we're taking to position Leidos for an awesome future.
first, continuing to unlock full value and flawless execution in our new capabilities-focused organization; second, increasing investment in distinct organic disruptive technologies; and third, developing a robust value-creating, merit-based Leidos' profit and growth strategy.
Thanks, Tom, and thanks to everyone for joining us today. The first quarter operating in our new organization was a great one, far surpassing our initial expectations. While Health and Civil was a standout, each segment's relentless focus on innovation and operational efficiency led to above-plan performance in revenue, profit and cash in every reporting segment. Putting these results into the context of the full year, we are well on track to deliver an exceptional year of top and bottom line performance.
[Operator Instructions]
Tom, when you started, I guess, about a year ago, you said you wanted to evaluate allocation of capital to each business based on the business case supporting the return on capital for each. It would seem like capital is being put to best use right now in Health and Civil. Is that a near-term phenomenon being driven by the PACT Act? Or is there a case for that business to be your fastest growing and most profitable longer term as well?
I did say that, and I do believe in a merit-based strategy process. I mentioned that in my prepared remarks because what we are doing in 2024 as we undertake this year of deep strategic thinking is analyzing all the business cases and the sub business cases for where the best use of capital is to draw a superior top line and bottom line growth for Leidos.
I just -- obviously, the Health and Civil organization has been a standout, and we do see that momentum continuing. And to Tom's point, it's been a multiyear investment strategy that's positioned us to be where we are and to deliver excellent results for our veterans and be rewarded for that. But there are other parts of the portfolio we're very excited about, too.
That's great. And Tom, you spent -- and Chris, you just mentioned it there. You spent several minutes in your prepared remarks talking about AI. I think one of your peers gets a lot of credit for sort of being the leader in the industry on AI and has taken some steps to break out like what their sales are and how it impacts their win rate on certain contracts.
Well, thanks, Bert. Yes. And yes, the fun thing about capitalism is many people look at the same market and decide to prosecute it in different ways.
Our next question comes from the line of Tobey Sommer with Truist Securities.
This is Jasper Bibb on for Tobey. I think last call, you talked about the initial mid- to high 10% guidance range on margin as a base sustainably grow off. And then you raised the '24 guides significantly this quarter. So I guess looking forward, how are you thinking about progression on margins given the progress you've already made this year?
Yes, Jasper, thanks for that, right. Obviously, we're very pleased with the start to the year. And as in our prepared remarks, we indicated it wasn't just the Health and Civil business. It was really all of our teams got out of the gate strong.
Just pivoting off of that a little bit, I want to give a shout-out to the team for how they've embraced this whole concept of promises-made, promises-kept culture. So while we have a standout first quarter performance in our Health business, they are not the only business committed to continuing to perform through the year.
That makes sense. And then you mentioned the improvement in managed health programs for Health and Civil segment this quarter. I guess just curious what the trends were on the legacy Civil side of the segment as part of the growth in margins Leidos had driven in the first quarter.
Yes. The Civil part of the portfolio has some excellent programs in there. And as Leidos and the team are bringing that all together, it's more about the energy and the synergies that we see across those businesses on personnel and in software capabilities that can be extended to both sides of the equation. I wouldn't think there's any particular standouts in the Civil portfolio. It was a solid first quarter out of the gate.
But I can't let that question not go without a little bit of a foot stomp on the great performance we're having in the Health side of the business. We are continuing to invest in innovation there. And some of the innovations that Bert asked us about before that were built during the COVID crisis puts us in this position to do exams better for the VBA and some of the results that are behind the financial results are that Leidos investments have allowed us to increase the total number of veterans served by 27% in 2023.
Our next question comes from the line of Sheila Kahyaoglu with Jefferies.
Kudos to the Leidos Board for choosing the right candidate, clearly, Tom, great results, the whole Leidos team. So maybe on Health, we talked about it a little bit and Chris mentioned it in his remarks in terms of the PACT Act moderation. Can you maybe frame how we should think about the upside and downside scenarios there?
Yes. So the PACT Act volumes are racing forward. We're in a unique position to liquidate that volume on behalf of the Veterans Administration and feel very good about that. But as Chris mentioned in his comments, that puts pressure on reaching the contract ceiling value for the Veterans Administration, and they may have to -- and they will have to recompete that contract early. However, we've got a great position for that recompete.
Yes, Sheila, I'd just add, I mean, we have invested. We'll continue to invest in increasing our ability to drive throughput and drive excellent service for the veterans. We've gotten the strongest signal yet from the customer that the volume of activity should remain elevated, and we see that continuing into 2025. And it's not just the number of cases, it's the complexity of those cases.
And then maybe on Defense Systems margins, they were better sequentially but down 170 bps year-on-year. So how do we think about maybe just focusing on Dynetics, the key milestones there in terms of improvement in profitability?
Yes. So I mean, a couple of things we're tracking, and Cindy, leading that business is all over this with her team. But as we said in our remarks, we're actually pleased with the way we performed out of the gates in the first quarter. We're ahead of pace.
Yes. And just to foot stomp that a little bit, Sheila. I mentioned -- as I foot-stomped an earlier comment about all the businesses keeping up with their commitments to Chris and I for their full year performance and the promises-made, promises-kept modus operandi, and I'm very happy to report that Cindy is amongst them, undeterred by a less robust start to the year than perhaps we might have hoped for, but very committed to the full year results, and she and her team are committed to meeting or exceeding those.
Our next question comes from the line of Seth Seifman with JPMorgan.
This is Rocco for Seth. On margins, milestone achievements supported the National Security and Digital margin in the quarter. Should we expect additional milestones in the coming quarters? Or should the margin rate there normalize? And then on Health and Civil, Q2 is expected to be as stronger as Q1, but should we think about the back half falling into the mid-teens on margins [ seen as strongest ] in the business, obviously, pending the recompete?
Yes, I'll start and Tom can jump on. Obviously, National Security and Digital, excellent program execution is what we expect from that team because they've consistently delivered it. And sometimes you're not able to anticipate that you'll knock it out of park on award fees the way they have continued to do so, but I wouldn't bet against them.
I would just say that my whole promises-made, promises-kept culture, never uninvites overperformance. And so overperformance is welcomed. Overperformance is understood as a goal we all look to achieve and I have every confidence, Roy and his team are going to work to overperform both in this year and the future. We haven't talked about it yet, but our business development pipeline is very exciting and very robust.
Great. And then should we expect hypersonics to drive Defense Systems growth this year or when the business is changing to limit growth?
Well, hypersonics is one of several areas that we're focused on in our Defense Systems business. And yes, we are very excited about the capabilities we've proven in our hypersonics programs. And in fact, this week, we're having very robust conversations with customers around where they want to go and how they want to take that technology forward.
Our next question comes from the line of Matt Akers with Wells Fargo.
I wonder if you could comment on the security products business. I think you said in the prepared remarks, there's still work to be done optimizing that. So I was just curious if you could touch on -- I think you are in-sourcing some products you talked about that last year. And then kind of how big should we think about some of these products that you've decided to exit?
We are very, very proud of Vicki and her team and the swift actions they've taken through last year and since last year. They're engaged, they're excited about the opportunities they see. And I'm very happy that they're not looking at that world through rose-colored glasses. They are being positively inclined pragmatists, looking at the market for what it is and looking at how we prosecute that market in the Leidos way to the best degree possible.
And I would just add, I mean, we're excited about getting our Charleston facility up and running. And the teams have been doing a good job there. Actually, the leadership team will be down there next week to lay eyes on it ourselves.
Great. And then I also want to ask on CapEx. A little bit of a slow start to the year. I might have missed it, but is the $190 million still the right way to think about that for this year? And does that sort of ramp up the year?
Yes, Matt, that's still our budget, and there's a little bit of reserve in there. And we ask the teams to be smart and disciplined even when we allocate them approvals. But you'll see a few things ramp up. We've got our San Diego facility that we're going to be proud of to get a brand-new facility for a lot of our classified work out in San Diego completed this summer, and the teams are also looking for interesting ways that we can get in front of the customer on unmanned capabilities, demos, tests, et cetera. So we expect that to ramp up a little bit, but we'll continue to manage that tightly.
Chris mentioned San Diego a little bit. I'll just foot-stomp the great job the team is doing there. We're building a facility that will be world-class in terms of security and up to the latest standards of our nation. And so we'll have facilities on the West Coast that are as good as any and better than most. And we're very excited about the conversations and the opportunities that will unlock for us with our customers and the opportunity, therefore, to serve them at the highest classification levels.
Our next question comes from the line of Noah Poponak with Goldman Sachs.
So I guess on the margins, in the quarter, the total company EBITDA margin over 12% despite what you're saying about Defense Systems and the back half of last year kind of mid-11s with the same thing and a little bit more normal Health margin. I guess just without even putting a time frame on it, but just as you go forward beyond this year, should we all be thinking of Leidos as a 12% plus EBITDA margin business? Or is that getting ahead of ourselves, depending on where Health and Civil shake out?
Well, no, we're not in the point where we're guiding to 2025 and beyond. But I remember last year, when we were wrapping up the year, we were talking about us being high-10s business and people were chastising me for suggesting we might be over 11%.
Well, mid- to high 11s. Tom, I just want to make sure the team doesn't run away from us here on their models. But no, your points are well made. I think that we have lines of business that haven't reached their full potential, and we're driving them in that direction.
Okay. And Tom, you sound pretty positive on bid and proposal. It sounds like you're making changes there as well. The company has had a lot of growth in the all-in total backlog number. It's been kind of flatter on that funded number and the funded book-to-bill or your stated book-to-bill, it's been decent, but it's seen higher numbers in the past, I guess. Are you expecting or should we be expecting that -- those numbers to improve through this year? Or does it take you a little more time to make any changes you're making on the BNP side?
And yes, we've put the right team in place to execute the vision for us being a growing business profitably, focused on profitable growth. And so the pipeline is being refined to go after aggressively the right business, not all business. You remember one of my sayings, not all business is good business. And for Leidos, people understand that message and our priming the pump of the pipeline accordingly. We've got a healthy backlog, as you rightly call out, I'm not a big fan of these quarterly book-to-bill ratios because they are a fool's mission.
Our next question comes from the line of Cai von Rumohr with TD Cowen.
Tom, good work on medical exams, terrific numbers. So you mentioned that you're approaching the ceiling on the medical exam. Can you tell us approximately when you might hit that ceiling? And can you give us any range of time frame in terms of when we might expect a new RFP?
Cai, this is Chris. Again, the team has done great work, and we're proud to serve our veterans, and it's been volumes that the customer didn't see coming when the original contracts were put in place. So the ceiling is structured differently. It's based upon an exam volume, and they've actually had to issue a justification authorization to extend that once already to give them time to run this competitive process.
Obviously, Cai, you'll appreciate the fact that our nation can afford the gap is critical capability for those who have served us. And so we are very appreciative that the Veterans Administration is working with alacrity around the whole of the system and how they keep serving our veterans adequately. And we're very much in dialogue with them to make sure that we're positioned to make sure our veterans continue to be served.
Got it. And so you've done way better than most of the other services business. Is there any risk or thought that because you're doing so well that the next bids might be structured so that there's not the same profit opportunity because obviously, I would assume, this has got to attract lots and lots of bidders. Or do you have any visibility at all or thought about how the VA might structure the next RFP?
I think the long and short answer to that, Cai, is no, we don't yet. They're still working through that themselves. But we feel very confident in the investments we've made and the facilitation that we've done, the technology we've deployed, the team we've assembled that we're in a very good place to compete and continue to serve our nation and the Veterans Administration.
Our next question comes from the line of Robert Spingarn with Melius Research.
So Tom, I wanted to start with a big-picture question, and it's about AI, you talked about it earlier. This is a little bit more from the industry perspective, but you and your competitors generate 60% or more of your sales from cost plus and time and materials contracts.
Rob, what we're looking at with AI, and I mentioned it in my prepared remarks, is really becoming that conduit from commercial best practices and GenAI technologies into the government space. You'll appreciate as well as anybody the fact that the government space and the government systems have a whole bunch of idiosyncrasies and complications that people like Leidos and Leidos in particular, know very well.
Rob, it's a good question. It's a good insight. I think we take the view that you've got to play the long game here. I mean if we were worried about maximizing the dollar on the current book of cost-plus contracts, I think that'd be a little bit shortsighted.
And that's a real interesting answer. And then, Chris, just not so much following on to that, but talking about cost plus, again, I think if we look at the other side of that, I think, around 40% of revenues are fixed price. So a pretty meaningful portion. I'm wondering, I want to ask you about stale backlog. If the backlog reflects that 40%, in other words, it's similar to the revenue profile. Is there any portion of that, that has pre-inflation pricing where you'd get a natural lift in margins as that work rolls off over the next couple of years and things are repriced post-inflation?
Rob, on inflation, I get where you're going with that. And I mean there's -- I'd say there's pockets of that, but there's not a pervasive opportunity or concern in our current backlog. I mean a lot of it as we priced our backlog on multiyear jobs, even if it's fixed price, we built in some inflationary expectation.
Operator, it looks like we only have time for one more question.
Our final question comes from the line of Jason Gursky with Citi.
Tom, you mentioned during the quarter and then here again on the call today, the Munich Security Conference and the somber event that it was. I'm just curious from a demand perspective coming out of Europe, kind of what you at Leidos are seeing these days. And how do you go about taking advantage of the demand signals that you're seeing in Europe at this point kind of given where you operate on that side of the pond, so to speak? And what kinds of programs you might be chasing over there?
Yes, it was a somber sobering affair. For those of you who haven't picked up the magazine that they published at the beginning, the title of the conference was lose-lose question mark. So that gives you a sense of the tone earlier this year. And I don't think that, that has become any more joyful.
And then just the last one on the pipeline that you have in front of you here domestically, maybe you could just talk about what you're seeing from a competitive perspective here of late and just general trends on the competitive environment would be great.
Yes. So we're doing reasonably well in defending the work we have. Our recompetes and on-contract growth is good, and we are very happy with our performance there. The retooling in our business capture and growth areas is all about going after the big game and making sure we put ourselves in a position to robustly prosecute new opportunities for Leidos.
Yes, Jason, just quickly, I mean, I'd say that certainly, best value or decisions are the trend we continue to see. And I'm not seeing any Crazy Ivans and the competitive set is pretty well known and understood. We pay a lot of attention to that. Oftentimes, it just comes down to are you writing a compelling proposal, getting clarity of what your solution, and do you have the unparalleled customer understanding that you need to really hit the mark on the things that they're looking for that might not have jumped out in the RFI.
This concludes the Q&A portion. I'll now turn the call back over to Stuart Davis for closing remarks.
Thank you, operator, for your assistance on this morning's call, and thank you all for your time this morning and your interest in Leidos. We look forward to updating you again soon. Have a great day.
This concludes today's conference call. Thank you for your participation. You may now disconnect. Everyone, have a wonderful day.